We are live on ! Find out more
LCP

Lamond Capital Partners Portfolio holdings

AUM $14.3M
1-Year Est. Return 30.74%
This Fund
S&P 500
This Quarter Est. Return
-14.52%
1 Year Est. Return
-30.74%
3 Year Est. Return
+54.28%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$98.5M
AUM Growth
+$6.99M
Cap. Flow
+$21.5M
Cap. Flow %
21.79%
Top 10 Hldgs %
98.51%
Holding
17
New
5
Increased
5
Reduced
1
Closed
6

Top Buys

Rank Stock Value
1
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$14.7M
2
VMEM
VIOLIN MEMORY, INC.
VMEM
+$11.4M
3
HPQ icon
HP
HPQ
+$11M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$9.77M
5
AMGN icon
Amgen
AMGN
+$7.86M

Top Sells

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$15.6M
2
GILD icon
Gilead Sciences
GILD
+$11.8M
3
NMBL
Nimble Storage, Inc.
NMBL
+$8.03M
4
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
+$5.86M
5
BLOX
Infoblox Inc
BLOX
+$5.02M

Sector Composition

Rank Sector Weight
1 Healthcare 59.92%
2 Technology 26.2%
3 Industrials 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
1
Ocular Therapeutix
OCUL
$1.86B
$15M 15.19%
711,533
+291,290
+69% +$7.22M
AMGN icon
2
Amgen
AMGN
$203B
$14.8M 15.06%
96,630
+49,040
+103% +$7.86M
SIOX
3
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$14.1M 14.34%
+86,620
New +$14.7M
ALXN
4
DELISTED
Alexion Pharmaceuticals
ALXN
$10.2M 10.39%
+56,610
New +$9.77M
HPQ icon
5
HP
HPQ
$23.5B
$10.1M 10.27%
+742,074
New +$11M
VMEM
6
DELISTED
VIOLIN MEMORY, INC.
VMEM
$9.64M 9.79%
983,645
+871,620
+778% +$11.4M
HOS
7
DELISTED
Hornbeck Offshore Services, Inc.
HOS
$7.24M 7.35%
+352,720
New +$7.73M
KITE
8
DELISTED
Kite Pharma, Inc.
KITE
$6.43M 6.53%
105,498
+1,248
+1% +$71.2K
BLOX
9
DELISTED
Infoblox Inc
BLOX
$6.05M 6.14%
230,872
-199,050
-46% -$5.02M
ALPN
10
DELISTED
Alpine Immune Sciences Inc
ALPN
$3.41M 3.46%
+56,250
New +$3.35M
BLCM
11
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.46M 1.49%
6,878
+3,178
+86% +$779K
GILD icon
12
Gilead Sciences
GILD
$161B
– –
-120,000
Closed -$11.8M
ZNGA
13
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
– –
-1,580,770
Closed -$4.5M
GWPH
14
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-171,496
Closed -$15.6M
NMBL
15
DELISTED
Nimble Storage, Inc.
NMBL
– –
-360,100
Closed -$8.03M
KING
16
DELISTED
KING DIGITAL ENTMT PLC ORD SHS (IRL)
KING
– –
-102,720
Closed -$1.65M
TRAK
17
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
– –
-151,990
Closed -$5.86M

Similar funds

HCM
Hirzel Capital Management Dallas, Texas $15.1M AUM 5.29% 1-Year Est. Return
PPF
PartnerRe Principal Finance Greenwich, Connecticut $15.5M AUM 13.01% 1-Year Est. Return
PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
TSU
TD Securities (USA) New York $11M AUM 2.35% 1-Year Est. Return
RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
SCA
Strategic Capital Alternatives Gig Harbor, United States $6.3M AUM
GFWEV
G.F.W. Energy VII Irving, Texas $1.49M AUM 89.53% 1-Year Est. Return
STA
System Two Advisors Summit, New Jersey $23K AUM 23.64% 1-Year Est. Return

Lamond Capital Partners's Q2 2015 Portfolio in Review

As of Q2 2015, Lamond Capital Partners held 17 positions worth $98.5M, up 7.6% from $91.5M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Lamond Capital Partners deployed $21.5M of net new capital in Q2 2015, opening 5 new positions and adding to 5 existing holdings. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 86,620 shares worth $14.1M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 58% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Infoblox Inc, an estimated $5.02M trimmed.

  • Lamond Capital Partners's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 86,620 shares worth $14.1M.
  • Lamond Capital Partners added most to VIOLIN MEMORY, INC. in Q2 2015, an estimated $11.4M increase.
  • Lamond Capital Partners's biggest Q2 2015 reduction was Infoblox Inc, cutting an estimated $5.02M.
  • Lamond Capital Partners fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2015, selling an estimated $15.6M.
  • Lamond Capital Partners's ten largest holdings make up 99% of its $98.5M portfolio in Q2 2015.
  • Lamond Capital Partners opened 5 new positions and closed 6 in Q2 2015.
  • Lamond Capital Partners's portfolio value rose 7.6% quarter-over-quarter to $98.5M.

Based on Lamond Capital Partners's 13F filing for Q2 2015, filed 7 Aug 2015.